Articles dans des revues avec comité de lecture (37)
1.
Kaufmann, T., Petkovic, M., Watkins, T. B. K., Colliver, E., Laskina, S., Thapa, N., Minussi, D., Navin, N., Swanton, C., Van Loo, P., Haase, K., Tarabichi, M., & Schwarz, R. F. (2022). MEDICC2: whole-genome doubling aware copy-number phylogenies for cancer evolution. Genome biology, 23(1). doi:10.1186/s13059-022-02794-92.
Paternot, S., Raspé, E., Meiller, C., Tarabichi, M., Assié, J.-B., Libert, F., Remmelink, M., Bisteau, X., Pauwels, P., Blum, Y., Le Stang, N., TABONE-EGLINGER, S., Galateau-Salle, F., Blanquart, C., van Meerbeeck, J. P., Berghmans, T., Jean, D., & Roger, P. P. (2022). Preclinical evaluation of CDK4 phosphorylation predicts high sensitivity of pleural mesotheliomas to CDK4/6 inhibition. Molecular Oncology. doi:https://doi.org/10.1002/1878-0261.133513.
Steele, C. D., Abbasi, A., Islam, S. M. A., Bowes, A. L., Khandekar, A., Haase, K., Hames-Fathi, S., Ajayi, D., Verfaillie, A., Dhami, P., McLatchie, A., Lechner, M., Light, N., Shlien, A., Malkin, D., Feber, A., Proszek, P., Lesluyes, T., Mertens, F., Flanagan, A. M., Tarabichi, M., Van Loo, P., Alexandrov, L. B., & Pillay, N. (2022). Signatures of copy number alterations in human cancer. Nature (London), 606(7916), 984-991. doi:10.1038/s41586-022-04738-64.
Drews, R. M., Hernando, B., Tarabichi, M., Haase, K., Lesluyes, T., Smith, P. S., Morrill Gavarró, L., Couturier, D. L., Liu, L., Schneider, M., Brenton, J. D., Van Loo, P., Macintyre, G., & Markowetz, F. (2022). A pan-cancer compendium of chromosomal instability. Nature (London), 606(7916), 976-983. doi:10.1038/s41586-022-04789-96.
Zoumpoulidou, G., Alvarez-Mendoza, C., Mancusi, C., Ahmed, R. M., Denman, M., Steele, C. C., Tarabichi, M., Roy, E., Davies, L. L., Manji, J., Cristalli, C., Scotlandi, K., Pillay, N., Strauss, S. J., & Mittnacht, S. (2021). Therapeutic vulnerability to PARP1,2 inhibition in RB1-mutant osteosarcoma. Nature communications, 12(1), 7064. doi:10.1038/s41467-021-27291-87.
Tarabichi, M., Demetter, P., Ruscas-Craciun, L. I., Maenhaut, C., & Detours, V. (2021). Thyroid cancer under the scope of emerging technologies. Molecular and cellular endocrinology, 541, 111491. doi:10.1016/j.mce.2021.1114919.
Steele, C. D., Abbasi, A., S. M. Ashiqul, I., Khandekar, A., Haase, K., Hames, S., Tarabichi, M., Lesluyes, T., Flanagan, A. M., Mertens, F., Van Loo, P., Alexandrov, L. B., & Pillay, N. (2021). Signatures of copy number alterations in human cancer. BioRxiv. doi:10.1101/2021.04.30.44194010.
Dentro, S. C., Leshchiner, I., Haase, K., Tarabichi, M., Wintersinger, J. J., Deshwar, A. G., Yu, K., Rubanova, Y., Macintyre, G., Demeulemeester, J., Vázquez-García, I., Kleinheinz, K., Livitz, D. G., Malikic, S., Donmez, N., Sengupta, S., Anur, P., Jolly, C., Cmero, M., Rosebrock, D., Schumacher, S., Fan, Y., Fittall, M., Drews, R. M., Yao, X., Watkins, T. B. K., Lee, J., Schlesner, M., Zhu, H., Adams, D. J., McGranahan, N., Swanton, C., Getz, G., Boutros, P. C., Imielinski, M., Beroukhim, R., Sahinalp, C., Ji, Y., Peifer, M., Martincorena, I., Markowetz, F., Mustonen, V., Yuan, K., Gerstung, M., Spellman, P. T., Wang, W., Morris, Q. D., Wedge, D. C., & Van Loo, P. (2021). Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomes. Cell, 184(8), 2239-2254.e39. doi:10.1016/j.cell.2021.03.00911.
Tarabichi, M., Demeulemeester, J., Verfaillie, A., Flanagan, A. M., Van Loo, P., & Konopka, T. (2021). A pan-cancer landscape of somatic mutations in non-unique regions of the human genome. Nature biotechnology. doi:10.1038/s41587-021-00971-y12.
Campbell, P. J., Sotiriou, C., Tarabichi, M., ICGC/TCGA Pan-Cancer Analysis of Whole Genomes Consortium,, et al. (2020). Pan-cancer analysis of whole genomes. Nature (London), 578(7793), 82-93. doi:10.1038/s41586-020-1969-6